Teva Pharmaceutical reported 848M in Selling and Administration Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aspen Pharmacare APN:SJ 4.61B 120M
Cipla CIPLA:IN 8.15B 296.4M
Dr.Reddys Laboratories DRRD:IN 21.72B 43M
Guangzhou Baiy 600332:CH 2.33B 1.11B
Jiangsu Hengrui Me. 600276:CH 2.99B 739.43M
Kalbe Farma Tbk Pt KLBF:IJ 1525.19B 353.86B
Richter Gedeon RICHT:HB 36.49B 4.37B
Sh Fosun Pharma 600196:CH 2.81B 378.88M
Sun Pharmaceuticals SUNP:IN 16.77B 430M
Teva Pharmaceutical TEVA:IT 848M 117M